Robertson Stephens Wealth Management LLC Cuts Stock Position in UnitedHealth Group Incorporated $UNH

Robertson Stephens Wealth Management LLC lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 17.8% in the 2nd quarter, Holdings Channel.com reports. The firm owned 6,204 shares of the healthcare conglomerate’s stock after selling 1,341 shares during the quarter. Robertson Stephens Wealth Management LLC’s holdings in UnitedHealth Group were worth $1,936,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently bought and sold shares of the business. Vanguard Group Inc. raised its position in UnitedHealth Group by 6.6% in the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock worth $47,519,620,000 after acquiring an additional 5,583,343 shares in the last quarter. Wellington Management Group LLP raised its position in UnitedHealth Group by 10.6% in the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock worth $13,537,859,000 after acquiring an additional 2,486,839 shares in the last quarter. Bank of New York Mellon Corp increased its position in shares of UnitedHealth Group by 2.5% in the first quarter. Bank of New York Mellon Corp now owns 8,128,174 shares of the healthcare conglomerate’s stock valued at $4,257,131,000 after buying an additional 196,696 shares in the last quarter. Nuveen LLC purchased a new position in shares of UnitedHealth Group in the first quarter valued at $3,846,764,000. Finally, Charles Schwab Investment Management Inc. increased its position in shares of UnitedHealth Group by 13.6% in the first quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate’s stock valued at $3,702,736,000 after buying an additional 847,054 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 3.6%

Shares of NYSE:UNH opened at $354.30 on Friday. The stock’s 50-day moving average price is $318.21 and its two-hundred day moving average price is $350.41. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73. The firm has a market cap of $320.88 billion, a price-to-earnings ratio of 15.35, a PEG ratio of 2.38 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm’s quarterly revenue was up 12.9% on a year-over-year basis. During the same period in the previous year, the business posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 38.30%.

Analyst Ratings Changes

A number of research analysts have recently weighed in on the company. Robert W. Baird restated an “underperform” rating and issued a $198.00 price target (down previously from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Wells Fargo & Company raised their price target on UnitedHealth Group from $267.00 to $400.00 and gave the company an “overweight” rating in a research report on Tuesday. Truist Financial increased their price objective on UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a research note on Tuesday, September 9th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $440.00 price objective on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Finally, KeyCorp increased their price objective on UnitedHealth Group from $350.00 to $400.00 and gave the company an “overweight” rating in a research note on Wednesday. Sixteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $383.09.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.